Skip to main navigation Skip to search Skip to main content

Phase III, randomized, placebo-controlled trial of CC-486 (Oral Azacitidine) in patients with lower-risk myelodysplastic syndromes

  • Guillermo Garcia-Manero
  • , Valeria Santini
  • , António Almeida
  • , Uwe Platzbecker
  • , Anna Jonasova
  • , Lewis R. Silverman
  • , Jose Falantes
  • , Gianluigi Reda
  • , Francesco Buccisano
  • , Pierre Fenaux
  • , Rena Buckstein
  • , Maria Diez Campelo
  • , Stephen Larsen
  • , David Valcarcel
  • , Paresh Vyas
  • , Valentina Giai
  • , Esther Natalie Olíva
  • , Jake Shortt
  • , Dietger Niederwieser
  • , Moshe Mittelman
    • Luana Fianchi, Ignazia La Torre, Jianhua Zhong, Eric Laille, Daniel Lopes de Menezes, Barry Skikne, C. L. Beach, Aristoteles Giagounidis

Research output: Contribution to journal › Article › peer-review

72 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase III, randomized, placebo-controlled trial of CC-486 (Oral Azacitidine) in patients with lower-risk myelodysplastic syndromes'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry